What is the pathophysiology of raised fasting blood glucose (FBS) with normal post‑prandial blood glucose (PPBS)?

Pathophysiology of Raised Fasting Blood Glucose with Normal Postprandial Blood Glucose

Raised fasting blood glucose (FBS) with normal postprandial blood glucose (PPBS) indicates predominant hepatic insulin resistance with preserved pancreatic beta-cell function and adequate prandial insulin response—the liver fails to suppress overnight glucose production despite adequate insulin to handle meal-related glucose loads.

Core Pathophysiologic Mechanisms

Hepatic Glucose Overproduction

The primary defect lies in increased hepatic glucose production during the fasting state, specifically through dysregulated gluconeogenesis 1, 2. In the fasting state, hyperglycemia is directly related to increased hepatic glucose production 2. Research demonstrates that individuals with impaired fasting glucose show increased rates of gluconeogenesis that are inadequately suppressed by insulin 3.

The liver continues producing glucose overnight at excessive rates because:

• Hepatic insulin resistance prevents normal suppression of gluconeogenesis
• Pancreatic alpha-cells hypersecrete glucagon, further promoting hepatic glucose production 2
• The combination creates persistent endogenous glucose production during fasting periods

Preserved Postprandial Mechanisms

The normal PPBS indicates that several compensatory mechanisms remain intact:

• Adequate first-phase insulin secretion: The pancreatic beta-cells can still mount an appropriate acute insulin response to meals 1
• Functional prandial insulin response: The second-phase insulin secretion remains sufficient to handle postprandial glucose loads 4
• Preserved peripheral glucose disposal: Skeletal muscle insulin sensitivity for glucose uptake after meals is relatively maintained
• Effective hepatic glucose suppression postprandially: During the fed state with higher insulin levels (approximately 300 pmol/L), even mildly insulin-resistant livers can adequately suppress glucose production 3

Clinical Context and Disease Progression

This pattern typically represents early-stage type 2 diabetes or impaired fasting glucose 1. The ESC/EASD guidelines define impaired fasting glucose as fasting plasma glucose 6.1-6.9 mmol/L (110-125 mg/dL) with 2-hour post-load glucose <7.8 mmol/L (<140 mg/dL) 1.

Why Fasting Glucose Rises First

Insulin resistance and impaired first-phase insulin secretion cause postprandial hyperglycemia in early disease, but fasting hyperglycemia develops as hepatic insulin resistance worsens 1. The progression follows this pattern:

1. Initial stage: Mild hepatic insulin resistance → elevated fasting glucose
2. Beta-cells compensate adequately for meals → normal postprandial glucose
3. As disease advances: Both fasting and postprandial glucose eventually rise

Research confirms that the relative contribution of fasting glucose increases progressively with worsening diabetes control 5. In fairly well-controlled patients (HbA1c <7.3%), postprandial glucose contributes 70% to overall hyperglycemia, but as control deteriorates, fasting glucose becomes the predominant contributor 6, 5.

Key Distinguishing Features

Hepatic vs. Peripheral Insulin Resistance

Studies using clamp techniques demonstrate that individuals with isolated elevated fasting glucose show:

• Mild hepatic insulin resistance with impaired suppression of gluconeogenesis 3
• Relatively preserved peripheral (muscle) insulin sensitivity for glucose disposal
• Higher visceral fat despite normal postprandial glucose handling 3

Hormonal Dysregulation

The pattern reflects:

• Inadequate basal insulin action on the liver overnight
• Preserved meal-stimulated insulin secretion and incretin effect
• Failure to suppress glucagon during fasting, maintaining hepatic glucose output 2

Clinical Implications

This glycemic pattern indicates early metabolic dysfunction where targeting fasting glucose through interventions that reduce hepatic glucose production (metformin, basal insulin optimization, lifestyle modifications reducing visceral fat) will be most effective 2. The preserved postprandial response suggests beta-cell reserve remains adequate, and aggressive prandial insulin therapy is not yet required.

Common Pitfall

Do not assume normal PPBS means diabetes is well-controlled or absent. Isolated fasting hyperglycemia meets diagnostic criteria for diabetes when fasting glucose ≥7.0 mmol/L (126 mg/dL) on two occasions 7, regardless of postprandial values. This represents established disease requiring treatment, not just a "pre-diabetic" state.